Impact of Different Types of Physical Activity in Patients With Chronic Inflammatory Bowel Disease
ACHILLE
1 other identifier
interventional
24
1 country
1
Brief Summary
This is a prospective interventional study. The investigators will include patients in clinical remission who are on stable treatment. These IBD patients will be followed to analyze the effects of physical activity on their inflammatory disease. Different exercises will be offered to two separate groups of randomly distributed patients: the first group will perform muscle building exercises while the other group will be offered aerobic exercises.There will also be a control group that does not initially benefit from a specific physical activity program. However, this group will be integrated into one of the other two groups after the 10-week follow-up. All three groups will perform the same baseline tests. These will be of different types: physical tests, biological tests and quality of life questionnaires.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 22, 2020
CompletedFirst Posted
Study publicly available on registry
October 19, 2020
CompletedStudy Start
First participant enrolled
January 5, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
February 7, 2023
CompletedMay 9, 2023
May 1, 2023
1.9 years
September 22, 2020
May 8, 2023
Conditions
Outcome Measures
Primary Outcomes (28)
Progressive effort test on bicycle ergometer (VO2 max)
This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)
day 1
Progressive effort test on bicycle ergometer (VO2 max)
This test allows to measure VO2 in ml/min/kg (thanks to respiratory gases)
through study completion, an average of 40 weeks
Progressive effort test on bicycle ergometer (Heart rate)
This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.
day 1
Progressive effort test on bicycle ergometer (Heart rate)
This test allows to measure resting and maximum heart rate (thanks to an ECG) and maximum aerobic power in Watt.
through study completion, an average of 40 weeks
Progressive effort test on bicycle ergometer (Power)
This test allows to measure maximum aerobic power in Watt.
day 1
Progressive effort test on bicycle ergometer (Power)
This test allows to measure maximum aerobic power in Watt.
through study completion, an average of 40 weeks
Maximum force test (N/m)
This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.
Day 1
Maximum force test (N/m)
This test will be performed using an isokinetic dynamometer. This evaluation will allow us to determine the maximum force of the quadriceps and hamstrings of each participant in N/m.
through study completion, an average of 40 weeks
Blood sample
This type of tests includes biological monitoring to obtain information on biological parameters.
Day 1
Blood sample
This type of tests includes biological monitoring to obtain information on biological parameters.
through study completion, an average of 40 weeks
Saddle analysis
This type of tests includes biological monitoring to obtain information on biological parameters.
Day 1
Saddle analysis
This type of tests includes biological monitoring to obtain information on biological parameters.
through study completion, an average of 40 weeks
IBD-F
Participants will complete a questionnaire on fatigue perceived.
Week 1
IBD-F
Participants will complete a questionnaire on fatigue perceived.
Week 10
IBD-F
Participants will complete a questionnaire on fatigue perceived.
Week 20
Godin Leisure Time exercise questionnaire
Participants will complete a questionnaire on the level of physical activity
Week 1
Metabolic Equivalent Task questionnaire
Participants will complete a questionnaire on the level of inactivity
Week 1
Metabolic Equivalent Task questionnaire
Participants will complete a questionnaire on the level of inactivity
Week 10
Metabolic Equivalent Task questionnaire
Participants will complete a questionnaire on the level of inactivity
Week 20
Short Food Frequency Questionnaire
Participants will complete a questionnaire on their dietary habits
Week 1
Short Food Frequency Questionnaire
Participants will complete a questionnaire on their dietary habits
Week 10
Short Food Frequency Questionnaire
Participants will complete a questionnaire on their dietary habits
Week 20
EQ5D questionnaire
Participants will complete a questionnaire on their level of health
Week 1
EQ5D questionnaire
Participants will complete a questionnaire on their level of health
Week 10
EQ5D questionnaire
Participants will complete a questionnaire on their level of health
Week 20
Short health scale questionnaire
Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease
Week 1
Short health scale questionnaire
Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease
Week 10
Short health scale questionnaire
Participants will complete a questionnaire to evaluate the level of the inflammatory bowel disease
Week 20
Study Arms (3)
Endurance training group
EXPERIMENTALResistance training group
EXPERIMENTALControl group
NO INTERVENTIONInterventions
This group will perform aerobic type exercises. Initially, patients will perform continuous exercises of progressive intensity in order to adapt to this kind of effort. Next, we will introduce interval exercises.
Patients in this group will perform lower limb strengthening exercises to improve the maximum strength of different muscle groups.
Eligibility Criteria
You may qualify if:
- Patients in remission defined by a Harvey Bradshaw Index 5 in Crohn's disease (CD) and a clinical Mayo 3 with no sub-score \>1 in ulcerative colitis (RCUH) with stable treatment, without corticosteroid for 4 months.
- Patients accepting the study protocol
You may not qualify if:
- Patients suffering from other pathologies (at the level of the digestive system, the cardiovascular system, as well as the musculoskeletal system: recent knee plasty, recent knee fractures, etc.), which can interfere with planned tests and activity programs.
- Patients with more than 3 hours of sports activity per week
- Pregnant, pregnant or nursing patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Université de Liège
Liège, 4000, Belgium
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 22, 2020
First Posted
October 19, 2020
Study Start
January 5, 2021
Primary Completion
December 15, 2022
Study Completion
February 7, 2023
Last Updated
May 9, 2023
Record last verified: 2023-05